C
CNS Healthcare | Clinical Neuroscience Solutions - Jacksonville
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Cariprazine
SDX
SEP-363856
Serdexmethylphenidate
EN3324
TRx0237
d-MPH
Centanafadine
AV608
Leuco-methylthioninium Bis(Hydromethanesulfonate)
Parent organization
This site is a part of CNS Healthcare
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 18 total trials
A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accept...
Enrolling
Generalized Anxiety Disorder
Drug: Placebo
Drug: SEP-363856
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Enrolling
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Trial sponsors
T
A
C
G
H
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems